{"id":"celecoxib-capsules","safety":{"commonSideEffects":[{"rate":"8-15%","effect":"Dyspepsia"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Headache"},{"rate":"2-5%","effect":"Hypertension"},{"rate":"2-5%","effect":"Edema"},{"rate":"1-3%","effect":"Cardiovascular events (myocardial infarction, stroke)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a selective COX-2 inhibitor, celecoxib preferentially blocks COX-2 enzyme activity while sparing COX-1, which is responsible for protective gastrointestinal and renal functions. This selectivity reduces prostaglandin-mediated inflammatory responses and pain signaling while theoretically minimizing gastrointestinal toxicity compared to non-selective NSAIDs. The drug is used to treat inflammatory conditions and pain by suppressing the inflammatory cascade at the prostaglandin synthesis level.","oneSentence":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:05:15.071Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Acute pain"},{"name":"Ankylosing spondylitis"}]},"trialDetails":[{"nctId":"NCT07351968","phase":"PHASE1","title":"A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-03-10","conditions":"Moderate Pain in Knee Osteoarthritis, Severe Pain in Knee Osteoarthritis","enrollment":200},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":"Osteo Arthritis Knee","enrollment":70},{"nctId":"NCT03590821","phase":"EARLY_PHASE1","title":"Timed Aspirin Chronobiome Study","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2027-12","conditions":"Healthy","enrollment":60},{"nctId":"NCT05077332","phase":"PHASE2","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","status":"COMPLETED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT07171034","phase":"PHASE1","title":"A Phase I Study of KLA318-2 Nanocrystal Injection","status":"RECRUITING","sponsor":"Hunan Kelun Pharmaceutical Co., Ltd.","startDate":"2025-09-01","conditions":"Healthy Participants","enrollment":48},{"nctId":"NCT05415397","phase":"PHASE3","title":"Treating Immuno-metabolic Depression With Anti-inflammatory Drugs","status":"RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2022-09-28","conditions":"Depressive Disorder, Major, Inflammation","enrollment":140},{"nctId":"NCT04115098","phase":"PHASE2","title":"Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-06-25","conditions":"Axial Spondyloarthritis","enrollment":42},{"nctId":"NCT06159114","phase":"PHASE4","title":"Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS","status":"COMPLETED","sponsor":"Xintian Pharmaceutical","startDate":"2023-12-19","conditions":"Chronic Prostatitis","enrollment":246},{"nctId":"NCT07104266","phase":"PHASE2","title":"Triple Negative Breast Cancer and Celecoxib. Pilot Study","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-08-04","conditions":"Triple-Negative Breast Cancer","enrollment":30},{"nctId":"NCT04767841","phase":"PHASE1, PHASE2","title":"The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2021-02-16","conditions":"Osteo Arthritis Knee","enrollment":""},{"nctId":"NCT04789837","phase":"PHASE1, PHASE2","title":"The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2021-03-01","conditions":"Osteoarthritis","enrollment":""},{"nctId":"NCT06516094","phase":"PHASE3","title":"Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-04-11","conditions":"Chronic Low-back Pain","enrollment":192},{"nctId":"NCT06863636","phase":"PHASE3","title":"Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation","status":"RECRUITING","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-09-09","conditions":"Joint Pain, Knee Osteoarthritis, Hip Osteoarthritis","enrollment":231},{"nctId":"NCT06340932","phase":"","title":"Impact of Opioid Avoidance Protocol for ACL Reconstruction","status":"COMPLETED","sponsor":"Matthew Varacallo","startDate":"2024-04-27","conditions":"ACL Tear, Post Operative Pain","enrollment":32},{"nctId":"NCT02030964","phase":"PHASE1","title":"N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan","status":"COMPLETED","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2014-01-16","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT04041050","phase":"PHASE1","title":"A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2019-11-08","conditions":"Myeloproliferative Neoplasm","enrollment":85},{"nctId":"NCT06603051","phase":"NA","title":"The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction","status":"RECRUITING","sponsor":"Virtua Health, Inc.","startDate":"2024-08-28","conditions":"ACL Repair","enrollment":20},{"nctId":"NCT06316843","phase":"PHASE2","title":"Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2","status":"COMPLETED","sponsor":"Bateman Horne Center","startDate":"2023-10-15","conditions":"Long COVID, PASC Post Acute Sequelae of COVID 19","enrollment":59},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT05281276","phase":"PHASE1","title":"Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)","status":"TERMINATED","sponsor":"Taipei Medical University Shuang Ho Hospital","startDate":"2022-09-20","conditions":"Metastatic Colorectal Cancer","enrollment":9},{"nctId":"NCT03643744","phase":"PHASE1","title":"Photodynamic Therapy-Induced Immune Modulation: Part III","status":"TERMINATED","sponsor":"Wright State University","startDate":"2019-04-01","conditions":"Actinic Keratosis, Photodynamic Therapy","enrollment":12},{"nctId":"NCT02993029","phase":"NA","title":"99Tc-MDP Treatment for Knee Osteoarthritis","status":"RECRUITING","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2017-09-01","conditions":"Treatment Outcome","enrollment":40},{"nctId":"NCT04765644","phase":"PHASE4","title":"Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2021-06-10","conditions":"Healthy","enrollment":44},{"nctId":"NCT05644301","phase":"PHASE3","title":"INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2023-09-21","conditions":"Major Depressive Disorder, Inflammation","enrollment":240},{"nctId":"NCT05077969","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","status":"TERMINATED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT06451783","phase":"EARLY_PHASE1","title":"Shengyu Decoction and Lijin Manipulation for Knee OA: 3D Gait Analysis","status":"ENROLLING_BY_INVITATION","sponsor":"Xuhui Central Hospital, Shanghai","startDate":"2024-05-01","conditions":"Osteoarthritis of the Knee","enrollment":94},{"nctId":"NCT01479829","phase":"PHASE4","title":"Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression","status":"COMPLETED","sponsor":"Loyola University","startDate":"2011-03-23","conditions":"Bipolar Depression","enrollment":100},{"nctId":"NCT06337422","phase":"PHASE1","title":"Bioequivalence Study of Generic Celecoxib 200 mg Capsules","status":"NOT_YET_RECRUITING","sponsor":"International Bio service","startDate":"2024-09-23","conditions":"Healthy Volunteer","enrollment":40},{"nctId":"NCT04790812","phase":"PHASE4","title":"Preemptive Analgesia With Celecoxib for Acute Dental Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-04-22","conditions":"Pain, Postoperative","enrollment":65},{"nctId":"NCT06328153","phase":"NA","title":"Efficacy and Mechanism of FSN Treatment for Senile Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2024-03-15","conditions":"Osteoarthritis, Knee","enrollment":60},{"nctId":"NCT04667169","phase":"NA","title":"Bleeding in Laser Haemorrhoidoplasty","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2015-01","conditions":"Hemorrhoids","enrollment":76},{"nctId":"NCT02688400","phase":"PHASE3","title":"Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis","status":"COMPLETED","sponsor":"TRB Chemedica International SA","startDate":"2016-05","conditions":"Osteoarthritis, Osteoarthritis, Knee","enrollment":380},{"nctId":"NCT05085574","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)","status":"WITHDRAWN","sponsor":"Leidos Life Sciences","startDate":"2023-02-07","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":""},{"nctId":"NCT05555823","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib","status":"COMPLETED","sponsor":"Atriva Therapeutics GmbH","startDate":"2022-06-23","conditions":"Healthy","enrollment":96},{"nctId":"NCT05911126","phase":"NA","title":"How to Reduce Pain in Patients Undergoing Office Hysteroscopy.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-13","conditions":"Pain","enrollment":180},{"nctId":"NCT03563690","phase":"NA","title":"Different Kinds of Acupuncture Treatment for Knee Osteoarthritis","status":"COMPLETED","sponsor":"Zhejiang Chinese Medical University","startDate":"2018-07-03","conditions":"Knee Osteoarthritis","enrollment":360},{"nctId":"NCT05765747","phase":"NA","title":"Effectiveness of Yunnan Baiyao in Improving Fracture Pain","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2023-04-01","conditions":"Distal Radius Fracture","enrollment":58},{"nctId":"NCT05324163","phase":"PHASE3","title":"Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis","status":"COMPLETED","sponsor":"Jiangsu XinChen-Techfields Pharma Co., LTD.","startDate":"2021-09-29","conditions":"KNEE OSTEOARTHRITIS","enrollment":180},{"nctId":"NCT03304379","phase":"PHASE3","title":"Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2017-10-26","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":1650},{"nctId":"NCT01765296","phase":"PHASE3","title":"Phase III Study of CG100649 in Osteoarthritis Patients","status":"COMPLETED","sponsor":"CrystalGenomics, Inc.","startDate":"2013-03","conditions":"Localized Primary Osteoarthritis of Hip, Localized Primary Osteoarthritis of Knee","enrollment":362},{"nctId":"NCT01341405","phase":"PHASE2","title":"Study of CG100649 Versus Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"CrystalGenomics, Inc.","startDate":"2011-04","conditions":"Osteoarthritis","enrollment":125},{"nctId":"NCT05436678","phase":"PHASE1","title":"A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablets Co-administered With Celecoxib Capsules, in Healthy Adult Subject","status":"COMPLETED","sponsor":"NeuroSense Therapeutics Ltd.","startDate":"2022-07-26","conditions":"Pharmacokinetics","enrollment":19},{"nctId":"NCT05438303","phase":"PHASE1","title":"Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-06-13","conditions":"Healthy Volunteers","enrollment":59},{"nctId":"NCT04673578","phase":"PHASE2","title":"Adjunctive Celecoxib in Childhood-onset OCD Study","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2021-06-01","conditions":"Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder","enrollment":80},{"nctId":"NCT05638893","phase":"PHASE2, PHASE3","title":"Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2021-02-01","conditions":"Knee Osteoarthritis","enrollment":50},{"nctId":"NCT05232461","phase":"PHASE1","title":"A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects","status":"COMPLETED","sponsor":"NeuroSense Therapeutics Ltd.","startDate":"2022-04-08","conditions":"Pharmacokinetics","enrollment":12},{"nctId":"NCT05547659","phase":"PHASE1, PHASE2","title":"Multimodal and Unimodal Analgesia in Cholecystectomy","status":"COMPLETED","sponsor":"October 6 University","startDate":"2019-01-01","conditions":"Compare Unimodal and Multimodal Analgesics","enrollment":95},{"nctId":"NCT05362851","phase":"PHASE3","title":"Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee","status":"UNKNOWN","sponsor":"Yooyoung Pharmaceutical Co., Ltd.","startDate":"2021-11-11","conditions":"Osteoarthritis, Knee","enrollment":692},{"nctId":"NCT05324995","phase":"PHASE2","title":"Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2021-01-01","conditions":"Postoperative Pain, Total Knee Arthroplasty","enrollment":146},{"nctId":"NCT01554163","phase":"PHASE3","title":"Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-03","conditions":"Osteoarthritis of the Knee","enrollment":239},{"nctId":"NCT01572675","phase":"","title":"A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-06","conditions":"Osteoarthritis","enrollment":547},{"nctId":"NCT04090684","phase":"PHASE1","title":"Ciprofloxacin/Celecoxib Combination in Patients With ALS","status":"COMPLETED","sponsor":"NeuroSense Therapeutics Ltd.","startDate":"2019-12-09","conditions":"ALS (Amyotrophic Lateral Sclerosis)","enrollment":10},{"nctId":"NCT03850587","phase":"PHASE2","title":"Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Yooyoung Pharmaceutical Co., Ltd.","startDate":"2018-08-30","conditions":"Osteoarthritis, Knee","enrollment":261},{"nctId":"NCT00359151","phase":"PHASE4","title":"Celebrex Total Knee Arthroplasty Study","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-11","conditions":"Osteoarthritis, Pain","enrollment":22},{"nctId":"NCT04165850","phase":"PHASE2","title":"Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS","status":"COMPLETED","sponsor":"NeuroSense Therapeutics Ltd.","startDate":"2019-11-25","conditions":"Amyotrophic Lateral Sclerosis, ALS","enrollment":16},{"nctId":"NCT00296127","phase":"PHASE1","title":"Study of Celecoxib Bioavailability in Healthy Subjects","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-02","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT00630929","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-01","conditions":"Osteoarthritis, Knee","enrollment":388},{"nctId":"NCT00662558","phase":"PHASE3","title":"A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-01","conditions":"Low Back Pain","enrollment":802},{"nctId":"NCT00633386","phase":"PHASE4","title":"Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-02","conditions":"Arthroscopy","enrollment":200},{"nctId":"NCT00633438","phase":"PHASE4","title":"Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-01","conditions":"Arthroscopy","enrollment":204},{"nctId":"NCT00620867","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2002-10","conditions":"Osteoarthritis, Knee","enrollment":393},{"nctId":"NCT00925106","phase":"PHASE1","title":"Pharmacokinetics Of Celecoxib Test Formulations","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-07","conditions":"Healthy Volunteers","enrollment":16},{"nctId":"NCT00762463","phase":"PHASE3","title":"Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-07","conditions":"Ankylosing Spondylitis","enrollment":240},{"nctId":"NCT00640627","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-12","conditions":"Osteoarthritis, Knee","enrollment":380},{"nctId":"NCT00638807","phase":"PHASE4","title":"Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-12","conditions":"Osteoarthritis, Knee","enrollment":388},{"nctId":"NCT00643799","phase":"PHASE4","title":"Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-03","conditions":"Osteoarthritis, Knee","enrollment":586},{"nctId":"NCT00640432","phase":"PHASE4","title":"Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-10","conditions":"Low Back Pain","enrollment":244},{"nctId":"NCT00813241","phase":"PHASE1","title":"A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-01","conditions":"Healthy Volunteers","enrollment":16},{"nctId":"NCT00640809","phase":"PHASE4","title":"Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-10","conditions":"Bowel Diseases, Inflammatory","enrollment":408},{"nctId":"NCT04639804","phase":"PHASE1","title":"Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2020-06-06","conditions":"Healthy","enrollment":60},{"nctId":"NCT03464552","phase":"PHASE4","title":"Celecoxib in Colposcopic Directed Biopsy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-04-15","conditions":"Colposcopy","enrollment":170},{"nctId":"NCT03672162","phase":"NA","title":"Preoperative Analgesia in Non-gynecological Cancerous Women Who Underwent Elective Total Abdominal Hysterectomy","status":"COMPLETED","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2019-02-01","conditions":"Total Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , Celecoxib","enrollment":90},{"nctId":"NCT03473665","phase":"PHASE4","title":"Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis","status":"TERMINATED","sponsor":"Columbia University","startDate":"2018-03-01","conditions":"Ankylosing Spondylitis, Axial Spondyloarthritis","enrollment":9},{"nctId":"NCT02429427","phase":"PHASE3","title":"European Celecoxib Trial in Primary Breast Cancer","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2005-12","conditions":"Breast Cancer","enrollment":2639},{"nctId":"NCT03570554","phase":"PHASE2","title":"A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-06-29","conditions":"Osteoarthritis, Knee","enrollment":41},{"nctId":"NCT02703259","phase":"PHASE4","title":"Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management","status":"COMPLETED","sponsor":"Christiana Care Health Services","startDate":"2016-06","conditions":"Pain, Postoperative","enrollment":137},{"nctId":"NCT04342065","phase":"PHASE2, PHASE3","title":"Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Spine Fixation Surgery","status":"COMPLETED","sponsor":"South Egypt Cancer Institute","startDate":"2019-01-01","conditions":"Post-Operative Pain","enrollment":200},{"nctId":"NCT03067194","phase":"PHASE4","title":"The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2016-12-27","conditions":"Osteoarthritis Hand","enrollment":117},{"nctId":"NCT03896113","phase":"PHASE2","title":"Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma","status":"UNKNOWN","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2019-11-13","conditions":"Endometrium Cancer","enrollment":48},{"nctId":"NCT03185871","phase":"PHASE2","title":"Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses","status":"WITHDRAWN","sponsor":"University of Wisconsin, Madison","startDate":"2017-09-20","conditions":"Breast Carcinoma","enrollment":""},{"nctId":"NCT02979197","phase":"PHASE3","title":"Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives","status":"COMPLETED","sponsor":"Kitov Pharma Ltd","startDate":"2016-11-03","conditions":"Hypertension","enrollment":105},{"nctId":"NCT02108366","phase":"PHASE3","title":"Treatment of Severe Influenza A Infection","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2014-03","conditions":"Influenza, Human","enrollment":107},{"nctId":"NCT01872910","phase":"PHASE2","title":"A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-06","conditions":"Acute Pain","enrollment":124},{"nctId":"NCT02961998","phase":"PHASE4","title":"Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2015-07","conditions":"Hepatocellular Carcinoma","enrollment":116},{"nctId":"NCT02192190","phase":"PHASE2","title":"A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2014-07","conditions":"Osteoarthritis, Knee","enrollment":268},{"nctId":"NCT04020588","phase":"PHASE4","title":"Anti-inflammatories and Adolescent Schizophrenia","status":"UNKNOWN","sponsor":"Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico","startDate":"2019-02-25","conditions":"Schizophrenia","enrollment":90},{"nctId":"NCT03059238","phase":"PHASE3","title":"Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2016-09","conditions":"Liver Cancer, Pain Postoperative","enrollment":213},{"nctId":"NCT02037165","phase":"PHASE1","title":"Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-01-21","conditions":"Healthy","enrollment":25},{"nctId":"NCT01449630","phase":"PHASE1","title":"A Study of LY3031207 in Healthy Subjects","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-10-24","conditions":"Healthy Volunteers","enrollment":29},{"nctId":"NCT01768520","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2012-07-02","conditions":"Knee Osteoarthritis","enrollment":338},{"nctId":"NCT01632566","phase":"PHASE1","title":"A Multiple-dose Study of LY3031207 in Healthy Participants","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2012-06","conditions":"Healthy Volunteers","enrollment":39},{"nctId":"NCT02362529","phase":"EARLY_PHASE1","title":"Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2015-02","conditions":"Major Depressive Disorder","enrollment":115},{"nctId":"NCT03921034","phase":"PHASE4","title":"IPACK Nerve Block for Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Ochsner Health System","startDate":"2016-11-17","conditions":"Arthropathy of Knee, Anesthesia","enrollment":72},{"nctId":"NCT02084511","phase":"PHASE1","title":"Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-03","conditions":"Pain, Postoperative","enrollment":80},{"nctId":"NCT03822520","phase":"PHASE1","title":"Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2017-06-30","conditions":"Qt Interval, Variation in","enrollment":28},{"nctId":"NCT03108482","phase":"PHASE3","title":"Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.","status":"COMPLETED","sponsor":"Esteve Pharmaceuticals, S.A.","startDate":"2017-03-14","conditions":"Acute Post-surgical Pain","enrollment":637},{"nctId":"NCT02172040","phase":"PHASE3","title":"Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy","status":"COMPLETED","sponsor":"Kitov Pharmaceuticals, Ltd.","startDate":"2014-06-26","conditions":"Hypertension","enrollment":152},{"nctId":"NCT03699293","phase":"PHASE4","title":"NSAIDs vs. Coxibs in the Presence of Aspirin","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2018-09-22","conditions":"Rheumatoid Arthritis, Cardiovascular Diseases","enrollment":30},{"nctId":"NCT03584074","phase":"PHASE4","title":"Clinical Trial of Pregabalin and COX2 in Spinal Stenosis","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2018-07-01","conditions":"Spinal Stenosis Lumbar","enrollment":60},{"nctId":"NCT01934933","phase":"PHASE4","title":"Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2014-09-24","conditions":"Ankylosing Spondylitis","enrollment":150}],"_emaApprovals":[],"_faersSignals":[{"count":60,"reaction":"DRUG INEFFECTIVE"},{"count":14,"reaction":"PAIN"},{"count":12,"reaction":"PRODUCT SUBSTITUTION ISSUE"},{"count":8,"reaction":"NAUSEA"},{"count":6,"reaction":"DIARRHOEA"},{"count":6,"reaction":"HEADACHE"},{"count":6,"reaction":"RASH"},{"count":4,"reaction":"ARTHRALGIA"},{"count":4,"reaction":"CHEST PAIN"},{"count":4,"reaction":"HYPOAESTHESIA"}],"_approvalHistory":[],"publicationCount":39,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Active comparator","Celebrex®","Celebra®"],"phase":"phase_3","status":"active","brandName":"Celecoxib capsules","genericName":"Celecoxib capsules","companyName":"Jiangsu XinChen-Techfields Pharma Co., LTD.","companyId":"jiangsu-xinchen-techfields-pharma-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain. Used for Rheumatoid arthritis, Osteoarthritis, Acute pain.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1999-12-23T00:00:00.000Z","mah":"GD SEARLE LLC","brand_name_local":"CELEBREX","application_number":"NDA021156"}],"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}